Preprotachykinin inhibitors belong to a specific chemical class of compounds meticulously designed to modulate the activity of the preprotachykinin protein. Preprotachykinin is a precursor protein that gives rise to neuropeptides such as substance P and neurokinin A, which play key roles in neurotransmission, pain perception, and other physiological processes. These inhibitors are thoughtfully crafted molecules engineered to interact with the preprotachykinin protein, influencing its normal function. Through these interactions, they might impact various cellular processes associated with neuropeptide synthesis, neurotransmission, and cellular responses, without directly altering its processing sites or its involvement in neuropeptide production.
The design of preprotachykinin inhibitors is grounded in a comprehensive understanding of the structural and functional attributes of the preprotachykinin protein. Typically developed using advanced chemical synthesis methods and informed by insights from neurobiology and neuropeptide signaling, these inhibitors are characterized by their ability to selectively bind to preprotachykinin. This selectivity enables focused modulation of cellular pathways that rely on the activity of this specific protein. Unraveling the intricacies of neurotransmission, pain perception, and cellular communication often employ preprotachykinin inhibitors as valuable tools. The development and utilization of preprotachykinin inhibitors contribute to advancing our knowledge of the complex interplay between neuronal components and neuropeptide dynamics, offering insights into the fundamental molecular mechanisms that govern neurotransmission and contribute to cellular responses to changes in neuropeptide signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aprepitant | 170729-80-3 | sc-207299 | 1 mg | $173.00 | 4 | |
Aprepitant is a neurokinin-1 (NK1) receptor antagonist. | ||||||
Fosaprepitant dimeglumine | 265121-04-8 | sc-483541 | 5 mg | $294.00 | ||
Fosaprepitant acts as an NK1 receptor antagonist. Inhibits PPT expression by blocking the upstream NK1 receptor and its effects on calcium, MAPK and epigenetic signaling cascades driving PPT transcriptional regulation. | ||||||
Netupitant | 290297-26-6 | sc-478156 | 5 mg | $419.00 | ||
Netupitant is an NK1 receptor antagonist used in combination with palonosetron to prevent chemotherapy-induced nausea and vomiting by inhibiting Preprotachykinin binding to NK1 receptors. | ||||||
CP 96345 | 132746-60-2 | sc-361160 sc-361160A | 5 mg 25 mg | $340.00 $849.00 | 1 | |
CP-96345 is a selective NK1 receptor antagonist that inhibits the binding of Preprotachykinin to its receptor, offering potential applications in pain management and other related conditions. | ||||||
RP 67580 | 135911-02-3 | sc-204894 sc-204894A | 10 mg 50 mg | $219.00 $898.00 | 4 | |
RP-67580 is a compound acting as an NK1 receptor antagonist, blocking the binding of Preprotachykinin and reducing its effects in various physiological and pathological processes. | ||||||